Open | 2.07 |
Previous Close | 1.96 |
Day Range | 1.91 - 2.08 |
52-Week Range | 1.80 - 21.96 |
All-Time High | 3,276.00 |
Avg. Volume (50-day) | 817,159.8 |
EPS (TTM) | -10.35 |
Next Earnings Date | - |
Last Earnings Date | - |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -0.19 |
PEG Ratio | - |
Price to Book | 7.69 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 0.12 M |
Revenue per Share (TTM) | 0.08 |
Shares Outstanding | 1.702 M |
Share Float (%) | 1.67 M |
% Held by Institutions | 12.21 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 3.1 (-36.77%) |
+/- SMA(50) | 4.6 (-57.39%) |
+/- SMA(200) | 5.66 (-65.37%) |
5-Day Perf. | -12.11% |
1-Month Perf. | -63.75% |
3-Month Perf. | -62.1% |
6-Month Perf. | -63.78% |
YTD Perf. | -64.49% |
1-Year Perf. | -84.29% |
RSI(14) | 33.62 |
ATR(14) | 0.7 |
ADX(14) | 12.7 |
Beta (5Y) | 0.88 |
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
ONVO has triggered the following predefined scans:
P&F Double Bottom Breakdown |
P&F Descending Triple Bottom Breakdown |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.